已发表论文

自体浓缩生长因子用于治疗剑术中的线状硬皮病: 1 病例报告

 

Authors Wang L, Lv S, Lin W, Yang D

Received 4 January 2022

Accepted for publication 1 April 2022

Published 14 April 2022 Volume 2022:15 Pages 675—679

DOI https://doi.org/10.2147/CCID.S356972

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Jeffrey Weinberg

Abstract: Linear scleroderma en coup de sabre (LSCS) is a variant of localized scleroderma associated with band-like fibrotic lesions in the frontoparietal area. We report a case of LSCS in a woman who presented with progressive mild hyperchromia on the right side of her forehead, with dermal atrophy and hair and eyebrow loss. After the failure of conservative treatments, the patient responded dramatically to injection of autologous localized concentrated growth factor. After three treatments, the atrophy, stiffness, and angiotelectasis on the affected area had improved. No recurrence was detected 24 months after the last treatment. This is the first study describing the use of autologous concentrated growth factor injection to alleviate clinical symptoms of LSCS. This suggests that concentrated growth factor may be a treatment for LSCS in the clinic.
Keywords: concentrated growth factor, linear scleroderma en coup de sabre